The financial movements and insider transactions at Globe Life Incorporated (NYSE:GL) offer a detailed look into internal confidence levels and the current valuation of the company. Central to this analysis is the recent activity involving Thomas P. Kalmbach, who serves as both Executive Vice President and Chief Financial Officer.
On May 22, 2026, Mr. Kalmbach executed a significant transaction: he sold 7,936 shares of common stock. This divestiture amounted to approximately $1,242,709, with the sales prices ranging between $156.25 and $157.08 per share.
This sale followed an earlier action on the same day when Mr. Kalmbach acquired 10,000 shares of common stock. These newly acquired shares were obtained through the exercise of employee stock options, valuing the transaction at $1,032,300. The cost basis for these exercised options was $103.23 per share.
The timing of these transactions is notable given that Globe Life shares are currently trading near their 52-week high of $157.92 and have delivered a substantial 32% return over the past year. Furthermore, according to InvestingPro analysis, the stock's current trading price is close to its stated Fair Value of $156.89. The company maintains a Price-to-Earnings (P/E) ratio of 10.85.
Following these recent transactions, Mr. Kalmbach’s direct ownership stake in Globe Life common stock is calculated to be 50,495.7065 shares. Regarding the options exercised, they had an exercise price of $103.23 per share and were scheduled to expire in February 2029. After completing this option exercise, he retains 10,000 unexercised options. In addition to his direct holdings, Mr. Kalmbach maintains an indirect ownership interest amounting to 1,152.787 shares through a 401(k) Plan.
Beyond the insider trading activity, Globe Life Inc. recently released its first-quarter earnings report for 2026. The results indicated that the company's earnings per share (EPS) slightly missed analyst forecasts. Specifically, Globe Life reported an EPS of $3.43, which fell short of the expected $3.48, representing a negative surprise of 1.44%. On a positive note, however, the company’s revenue successfully met market expectations at $1.56 billion.
These financial developments have prompted analysts to adjust their outlooks on Globe Life. Several major institutions provided updated recommendations:
- Raymond James raised its price target for GL to $208 from a previous valuation of $188, while maintaining a